Estrogenic protection against gp120 neurotoxicity: role of microglia

Ilona Zemlyak1, Sheila Brooke, Robert Sapolsky

  • 1Department of Biological Sciences, Neurology and Neurological Sciences, Stanford University, CA 94305-5020, USA. ilona.zemlyak@stanford.edu

Brain Research
|May 10, 2005
PubMed

Insights

Estrogen reduces neurotoxicity caused by HIV's gp120 protein. It primarily works by decreasing harmful factors released by microglia, with a smaller effect on enhancing neuron survival.

Area of Science:

  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • HIV infection can lead to nervous system damage (neurotoxicity).
  • The HIV glycoprotein gp120 is implicated in this neurotoxicity.
  • Estrogen has shown potential in mitigating gp120-induced neurotoxicity.

Purpose of the Study:

  • To investigate if estrogen reduces the toxicity of factors released by gp120-stimulated microglia.
  • To determine if estrogen enhances neuronal resilience against these toxic factors.

Main Methods:

  • Established separate microglial, mixed neuronal/glial hippocampal, and neuron-enriched cultures.
  • Manipulated gp120 and estrogen exposure in these cultures.
  • Assessed neurotoxicity using conditioned media from gp120-treated microglia.

Main Results:

  • Estrogen demonstrated a minor protective effect by increasing neuronal resistance.
  • The primary protective action of estrogen was found to be reducing the neurotoxicity of microglial-released factors.

Conclusions:

  • Estrogen's neuroprotective effects against HIV gp120 involve both bolstering neuronal defense and, more significantly, reducing microglial-derived neurotoxins.

Related Concept Videos